a phase ii clinical trial of an anthraquinone , mitoxantrone was performed in a total of 31 patients with various advanced solid tumors and 2 patients with malignant lymphomas refractory to extensive prior chemotherapies .
C0003174
anthraquinone
C0026259
mitoxantrone